ABIOSA PHARMA AS: årsregnskap 2021 vs 2020
Another loss-making year
approved 2022-06-30; registry 2022-08-02; journal 2022 849886
Summary
What changed
Comparing Årsregnskap 2021 with 2020 for ABIOSA PHARMA AS. Revenue 0 NOK → 0 NOK (0.0%). Net result -298 NOK → -300 NOK. Equity -8 584 NOK → -8 884 NOK.
Also worth watching: operating result unchanged; thin equity buffer. All figures are taken from the published annual accounts for ABIOSA PHARMA AS.
At a glance
Scorecard
Revenue
0 NOK
0 NOK
0.0%
Operating result
-300 NOK
-300 NOK
0.0%
Net result
-298 NOK
-300 NOK
-0.7%
Equity
-8 584 NOK
-8 884 NOK
-3.5%
Cash
7 779 NOK
7 479 NOK
-3.9%
Total assets
7 779 NOK
7 479 NOK
-3.9%
Things to notice
-
·
Operating result unchanged
Operating result -300 NOK → -300 NOK. Calculated
-
·
Thin equity buffer
Equity ratio is -118.8% of assets — limited loss-absorbing capacity on a stand-alone basis. Interpretation